He Xia, Li Yuhuang, Dai Mu-Shui, Sun Xiao-Xin
Department of Molecular and Medical Genetics, School of Medicine and The OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Department of Radiation Oncology, Jiangsu Cancer Hospital, Nanjing, China.
Oncotarget. 2016 Mar 29;7(13):16217-26. doi: 10.18632/oncotarget.7479.
A number of ribosomal proteins (RPs) have been shown to play a critical role in coordinating ribosome biogenesis with cell growth and proliferation by suppressing MDM2 to induce p53 activation. While how the MDM2-p53 pathway is regulated by multiple RPs is unclear, it remains to be interesting to identify additional RPs that can regulate this pathway. Here we report that ribosomal protein L4 (RPL4) directly interacts with MDM2 at the central acidic domain and suppresses MDM2-mediated p53 ubiquitination and degradation, leading to p53 stabilization and activation. Interestingly, overexpression of RPL4 promotes the binding of MDM2 to RPL5 and RPL11 and forms a complex with RPL5, RPL11 and MDM2 in cells. Conversely, knockdown of RPL4 also induces p53 levels and p53-dependent cell cycle arrest. This p53-dependent effect requires both RPL5 and RPL11, suggesting that depletion of RPL4 triggers ribosomal stress. Together, our results reveal that balanced levels of RPL4 are critical for normal cell growth and proliferation via regulating the MDM2-p53 loop.
一些核糖体蛋白(RPs)已被证明通过抑制MDM2以诱导p53激活,在协调核糖体生物合成与细胞生长和增殖中发挥关键作用。虽然多个核糖体蛋白如何调节MDM2-p53途径尚不清楚,但鉴定其他能够调节该途径的核糖体蛋白仍很有趣。在此我们报告,核糖体蛋白L4(RPL4)在中央酸性结构域直接与MDM2相互作用,并抑制MDM2介导的p53泛素化和降解,导致p53稳定和激活。有趣的是,RPL4的过表达促进MDM2与RPL5和RPL11的结合,并在细胞中与RPL5、RPL11和MDM2形成复合物。相反,RPL4的敲低也会诱导p53水平和p53依赖性细胞周期停滞。这种p53依赖性效应需要RPL5和RPL11两者,表明RPL4的缺失触发核糖体应激。总之,我们的结果揭示,RPL4的平衡水平通过调节MDM2-p53环对于正常细胞生长和增殖至关重要。